Protection against the Metabolic Syndrome by Guar Gum-Derived Short-Chain Fatty Acids Depends on Peroxisome Proliferator-Activated Receptor γ and Glucagon-Like Peptide-1

PLoS One. 2015 Aug 20;10(8):e0136364. doi: 10.1371/journal.pone.0136364. eCollection 2015.

Abstract

The dietary fiber guar gum has beneficial effects on obesity, hyperglycemia and hypercholesterolemia in both humans and rodents. The major products of colonic fermentation of dietary fiber, the short-chain fatty acids (SCFAs), have been suggested to play an important role. Recently, we showed that SCFAs protect against the metabolic syndrome via a signaling cascade that involves peroxisome proliferator-activated receptor (PPAR) γ repression and AMP-activated protein kinase (AMPK) activation. In this study we investigated the molecular mechanism via which the dietary fiber guar gum protects against the metabolic syndrome. C57Bl/6J mice were fed a high-fat diet supplemented with 0% or 10% of the fiber guar gum for 12 weeks and effects on lipid and glucose metabolism were studied. We demonstrate that, like SCFAs, also guar gum protects against high-fat diet-induced metabolic abnormalities by PPARγ repression, subsequently increasing mitochondrial uncoupling protein 2 expression and AMP/ATP ratio, leading to the activation of AMPK and culminating in enhanced oxidative metabolism in both liver and adipose tissue. Moreover, guar gum markedly increased peripheral glucose clearance, possibly mediated by the SCFA-induced colonic hormone glucagon-like peptide-1. Overall, this study provides novel molecular insights into the beneficial effects of guar gum on the metabolic syndrome and strengthens the potential role of guar gum as a dietary-fiber intervention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • AMP-Activated Protein Kinases / physiology
  • Animals
  • Blood Glucose / analysis
  • Calorimetry, Indirect
  • Cecum / chemistry
  • Dietary Fiber / therapeutic use*
  • Fatty Acids, Volatile / analysis
  • Fatty Acids, Volatile / metabolism*
  • Galactans / therapeutic use*
  • Glucagon-Like Peptide 1 / metabolism
  • Glucagon-Like Peptide 1 / physiology*
  • Glucose Tolerance Test
  • Insulin Resistance
  • Male
  • Mannans / therapeutic use*
  • Metabolic Syndrome / metabolism
  • Metabolic Syndrome / prevention & control*
  • Mice
  • Mice, Inbred C57BL
  • PPAR gamma / metabolism
  • PPAR gamma / physiology*
  • Plant Gums / therapeutic use*

Substances

  • Blood Glucose
  • Dietary Fiber
  • Fatty Acids, Volatile
  • Galactans
  • Mannans
  • PPAR gamma
  • Plant Gums
  • Glucagon-Like Peptide 1
  • guar gum
  • AMP-Activated Protein Kinases

Grants and funding

This work was funded by the Netherlands Genomics Initiative via the Netherlands Consortium for Systems Biology (91108004) from NWO/ZonMw. KVE and AB are currently receiving an unrestricted research grant from Top Institute Food and Nutrition. BMB was supported by a Rosalind Franklin fellowship from the University of Groningen.